Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study

被引:89
作者
Laky, Brenda [1 ]
Janda, Monika [2 ]
Kondalsamy-Chennakesavan, Srinivas [4 ]
Cleghorn, Geoffrey [3 ,4 ]
Obermair, Andreas [1 ,4 ]
机构
[1] Royal Brisbane & Womens Hosp, Queensland Ctr Gynaecol Canc, Herston, Qld 4029, Australia
[2] Queensland Univ Technol, Sch Publ Hlth, Brisbane, Qld 4001, Australia
[3] Royal Childrens Hosp, Childrens Nutr Res Ctr, Brisbane, Qld, Australia
[4] Univ Queensland, Sch Med, Brisbane, Qld, Australia
来源
BMC CANCER | 2010年 / 10卷
基金
英国医学研究理事会;
关键词
SUBJECTIVE GLOBAL ASSESSMENT; EPITHELIAL OVARIAN-CANCER; NUTRITIONAL-STATUS; PARENTERAL-NUTRITION; SERUM HEMOGLOBIN; LYMPHOCYTE COUNT; SURGERY; ONCOLOGY; SURVIVAL; PREDICTORS;
D O I
10.1186/1471-2407-10-232
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Length of hospital stay (LOS) is a surrogate marker for patients' well-being during hospital treatment and is associated with health care costs. Identifying pretreatment factors associated with LOS in surgical patients may enable early intervention in order to reduce postoperative LOS. Methods: This cohort study enrolled 157 patients with suspected or proven gynecological cancer at a tertiary cancer centre (2004-2006). Before commencing treatment, the scored Patient Generated - Subjective Global Assessment (PG-SGA) measuring nutritional status and the Functional Assessment of Cancer Therapy-General (FACT-G) scale measuring quality of life (QOL) were completed. Clinical and demographic patient characteristics were prospectively obtained. Patients were grouped into those with prolonged LOS if their hospital stay was greater than the median LOS and those with average or below average LOS. Results: Patients' mean age was 58 years (SD 14 years). Preoperatively, 81 (52%) patients presented with suspected benign disease/pelvic mass, 23 (15%) with suspected advanced ovarian cancer, 36 (23%) patients with suspected endometrial and 17 (11%) with cervical cancer, respectively. In univariate models prolonged LOS was associated with low serum albumin or hemoglobin, malnutrition (PG-SGA score and PG-SGA group B or C), low pretreatment FACT-G score, and suspected diagnosis of cancer. In multivariable models, PG-SGA group B or C, FACT-G score and suspected diagnosis of advanced ovarian cancer independently predicted LOS. Conclusions: Malnutrition, low quality of life scores and being diagnosed with advanced ovarian cancer are the major determinants of prolonged LOS amongst gynecological cancer patients. Interventions addressing malnutrition and poor QOL may decrease LOS in gynecological cancer patients.
引用
收藏
页数:6
相关论文
共 41 条
[1]   Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer [J].
Alphs, Hannah H. ;
Zahurak, Marianna L. ;
Bristow, Robert E. ;
Diaz-Montes, Teresa P. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :1048-1053
[2]  
[Anonymous], 2000, CLIN GUIDE ONCOLOGY
[3]   NUTRITIONAL ASSESSMENT - A COMPARISON OF CLINICAL JUDGMENT AND OBJECTIVE MEASUREMENTS [J].
BAKER, JP ;
DETSKY, AS ;
WESSON, DE ;
WOLMAN, SL ;
STEWART, S ;
WHITEWELL, J ;
LANGER, B ;
JEEJEEBHOY, KN .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (16) :969-972
[4]   Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer [J].
Bauer, J ;
Capra, S ;
Ferguson, M .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (08) :779-785
[5]  
BISHARA S, 2007, EUR J OBSTET GYNECOL
[6]  
BURNETT AF, 1993, J REPROD MED, V38, P137
[7]  
Caro MMM, 2007, CURR OPIN CLIN NUTR, V10, P480, DOI 10.1097/MCO.0b013e3281e2c983
[8]   Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening [J].
Cella, D ;
Hahn, EA ;
Dineen, K .
QUALITY OF LIFE RESEARCH, 2002, 11 (03) :207-221
[9]   QUALITY-OF-LIFE - CONCEPTS AND DEFINITION [J].
CELLA, DF .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1994, 9 (03) :186-192
[10]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579